AKRO
Akero Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AKRO Filings
Filing Date
Form Description
Form Type
2025-12-03
Form 8-K - Current report
Key Events
2025-12-03 · Key Events
Form 8-K - Current report
2025-11-28
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-28 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-24
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-11-24 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-11-21
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-21 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-12 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
